jury Alzheimer s and Parkinson
Selected Abstract
BTG Launches New Venture to Develop Breakthrough Technology to Treat Broad Array of Neurological Conditions; Ketone Body Approach Targets Major Disease Areas Including Stroke, Head Injury, Alzheimer's and Parkinson's Diseases.
WEST CONSHOHOCKEN, Pa. -- BTG , the global technology commercialization company, today launched KetoCytonyx, Inc., a company created to develop BTG's ketone body technology. KetoCytonyx Inc. will develop new treatments for acute brain injury such as stroke and head trauma and for chronic ... November 29, 2001; PR Newswire
Read the full article with a free-trial membership at HighBeam Research
Related Articles No Results Found.
|
